MedTrace Logo

Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease

NCT03519815 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2019-02-19

No results posted yet for this study

Summary

Subjective and objective evaluation of the efficacy and tolerability of preservative-free "Ectoin® Eye Spray - Colloidal" and comparison of the efficacy and tolerability between "Ectoin® Eye Spray - Colloidal" and Tears Again® in patients with mild-moderate dry eye disease

Conditions

  • Dry Eye

Interventions

DEVICE

Ectoin® Eye Spray - Colloidal

eye spray to be applied to the closed eye lid

DEVICE

Liposomal eye spray Tears Again®

eye spray to be applied to the closed eye lid

Sponsors & Collaborators

  • University of Applied Sciences and Arts Northwestern Switzerland

    lead OTHER

Principal Investigators

  • Daniela S Nosch, PhD · University of Applied Sciences and Arts Northwestern Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2018-10-30
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03519815 on ClinicalTrials.gov